Clinical Trial Update: A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina [Phase 3]

View source ↗

Summary

A Phase 3 therapeutic confirmatory trial evaluating cilostazol for vasospastic angina has completed, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasospastic Angina

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Vasospastic Angina | Phase 3 | Status: COMPLETED